Compounds > alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
Page last updated: 2024-09-04

alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile and Schizophrenia

alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blumhardt, CL; Doran, AR; Narang, PK; Pickar, D1

Other Studies

1 other study(ies) available for alpha-(3-aminopropyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile and Schizophrenia

ArticleYear
Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia.
    Clinical pharmacology and therapeutics, 1988, Volume: 44, Issue:5

    Topics: Administration, Oral; Adult; Blood Proteins; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Schizophrenia; Verapamil

1988